PFIZER INC Q4 2025 Filing

Filed February 12, 2026

Portfolio Value

$236.5M

Holdings

18

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (18 positions)

#StockSharesValue% PortfolioType
1
ORICORIC PHARMACEUTICALS INC
5,376,344$44.0M18.60%
2
ARVNARVINAS INC
3,457,815$41.0M17.34%
3
CELCCELCUITY INC
349,406$34.8M14.74%
4
WVEWAVE LIFE SCIENCES LTD
1,875,000$31.9M13.48%
5
ALLOALLOGENE THERAPEUTICS INC
22,032,040$30.2M12.76%
6
ZURAZURA BIO LTD
2,970,022$15.6M6.58%
7
PYXSPYXIS ONCOLOGY INC
7,032,770$8.1M3.42%
8
CRBUCARIBOU BIOSCIENCES INC
4,690,431$7.5M3.15%
9
CRDFCARDIFF ONCOLOGY INC
2,411,575$6.8M2.87%
10
BHVNBIOHAVEN LTD
505,645$5.7M2.41%
11
SPROSPERO THERAPEUTICS INC
2,362,348$5.5M2.33%
12
NXTCNEXTCURE INC
157,646$2.2M0.95%
13
ZNTLZENTALIS PHARMACEUTICALS INC
953,834$1.3M0.54%
14
QTTBQ32 BIO INC
277,777$922K0.39%
15
ANTXAN2 THERAPEUTICS INC
715,295$815K0.34%
16
BOLTBOLT BIOTHERAPEUTICS INC
31,305$171K0.07%
17
DNAGINKGO BIOWORKS HOLDINGS INC
2,928$24K0.01%
18
SENS1GBPSENSEONICS HLDGS INC
2,171$11K0.00%